What the product information lists
We searched the US labels, EU product information and Canadian monographs for halitosis, breath odour and bad breath and found no entry. The reactions that can plausibly change breath are listed, though, and they have numbers.
- Taste changes (dysgeusia) are also listed: 1.7% on Wegovy® against 0.5% on placebo, and 0.4% on Zepbound® against none [1][2]. A bad taste often goes with bad breath [10].
- The EU Ozempic® information warns that diabetic ketoacidosis has been reported in insulin-dependent people whose insulin was reduced quickly after starting a GLP-1 medicine, and its leaflet lists a sweet smell on the breath among the signs [5].
| Document | Burping | Reflux | Dry mouth | Vomiting |
|---|---|---|---|---|
| Wegovy®, US label, adults on 2.4 mg [2] | 7% vs under 1% | 5% vs 3% | Not listed | 24% vs 6% |
| Zepbound®, US label [1] | 4–5% vs 1% | 4–5% vs 2% | 1% vs 0.1% | 8–13% vs 2% |
| Saxenda®, US label, adults [3] | 4.5% vs 0.2% | 4.7% vs 1.7% | 2.3% vs 1.0% | 15.7% vs 3.9% |
| Foundayo™, US label [4] | 6–8% vs 1% | 6–7% vs 2% | Not listed | 13–24% vs 4% |
What reviews and studies say
A 2026 review for dentists and physicians lists bad breath among the oral signs that people taking semaglutide may present with, alongside dry mouth, enamel erosion from vomiting and altered taste, and explains them as knock-on effects of the medicine’s action on the stomach [6]. A second 2026 review describes a cluster of complaints, including what is popularly called “Ozempic breath”, linked to nausea, vomiting, burping and lower fluid intake, and stresses that human studies measuring oral health outcomes are still scarce [7].
Reflux is one of those knock-on effects with population data. In a UK cohort of adults with type 2 diabetes, starting a GLP-1 medicine was linked to a higher risk of a new reflux diagnosis than starting an SGLT-2 inhibitor; the absolute difference was under one person in a hundred over three years [8]. MedlinePlus and Cleveland Clinic both name reflux disease as a cause of bad breath [9][10].
How a GLP-1 medicine could change your breath
- Supported by the labels: slower stomach emptying, more burping and more reflux can bring stomach odours and acid up into the mouth [1][2].
- Supported by the labels: a dry mouth reduces saliva, which normally rinses the mouth; less saliva lets odour-causing bacteria build up [1][3][10][11].
- Supported by the labels: vomiting is common early in treatment [1][2][3]. Prolonged vomiting can itself change breath odour [9].
- Proposed but not measured: eating less and drinking less can leave the mouth drier between meals. This has not been studied directly in people on GLP-1 medicines.
- General: most bad breath comes from plaque bacteria in the mouth and on the tongue, and is linked to oral hygiene, gum disease, smoking and strong foods [9][10].
Other causes to consider
Cleveland Clinic lists poor oral hygiene as the main cause, followed by dry mouth, gum disease, tonsil stones, nose, throat or lung infections, diabetes, reflux, kidney or liver disease, smoking and, rarely, head and neck cancers [10]. MedlinePlus adds dentures, cavities, alcohol use, some foods, coffee, high-dose vitamin supplements and certain medicines [9].
Many medicines reduce saliva, including some for blood pressure, depression and bladder control [11]. Tell your clinician about any such medicine that began close to your GLP-1 start date.
What may help
Cleveland Clinic suggests brushing twice and flossing once a day, cleaning the tongue, cleaning any dental appliances, using an alcohol-free antibacterial mouthwash, seeing a dentist regularly, drinking water to prevent dry mouth, using sugar-free gum or mints to boost saliva, and avoiding alcohol, caffeine and tobacco [10]. MedlinePlus notes that mouthwash alone does not treat an underlying cause [9].
If burping or reflux is the likely source, raise it with your prescriber; the labels list both as common, and your prescriber can decide whether anything should change [1][2]. If a dentist finds no oral cause, Cleveland Clinic suggests seeing a primary care clinician next [10].
Ozempic®, Wegovy® and Saxenda® are registered trademarks of Novo Nordisk A/S. Zepbound® is a registered trademark and Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Novo Nordisk or Eli Lilly and Company.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| A fruity or sweet breath smell with strong thirst, fast breathing or confusion, especially with diabetes | Emergency services (112/911) | Emergency | MedlinePlus [9]; EU Ozempic® information [5] |
| Breath smelling like stool after long vomiting, with a swollen belly or no bowel movements | Emergency care | Emergency | MedlinePlus [9]; Zepbound® label, section 6.2 [1] |
| Bad breath with fever, cough or facial pain and nasal discharge | Your clinician | Today | MedlinePlus [9] |
| Bad breath that persists without an obvious cause such as food or smoking | Your dentist, then your clinician | At your next appointment | MedlinePlus [9]; Cleveland Clinic [10] |
| Frequent burping or heartburn since starting treatment | Your prescriber | At your next appointment | Wegovy® and Zepbound® labels [1][2] |
